YLYaping Liu

Yaping Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yaping Liu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Metal-Peptide Framework as a Nanozyme for the Attenuation of Amyloid-β Aggregation and Reactive Oxygen Species

    by Zhuo Zhang, Mingchen Lv, Jiaxi Xu, Yaping Liu, Jinlong Qin, Zhen Fan, Jianzhong Du

    Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by abnormal performance in memory, cognition, and language, and it imposes a heavy economic burden worldwide. Amyloidosis and oxidative stress are highly associated with AD progression, yet limited clinical drugs are available at present. Nanozymes exhibit diverse enzyme-mimetic activities and have attracted widespread attention as a promising alternative candidate for scavenging reactive oxygen species to maintain the oxidation–antioxidation balance in cells. Neurotoxic amyloid-β (Aβ) aggregation is also a critical event in AD pathology. The development of dual-targeting nanomaterials with antiamyloidosis ability and enzyme-mimicking activity is expected to be a promising strategy for the treatment of amyloidosis and reactive oxygen species-mediated AD progression. Here, bimetallic-peptide framework nanozymes (CuZn-PEP NZs) with amyloid-β (Aβ) attenuating ability, multiple enzyme-mimicking properties, and broad-spectrum reactive oxygen species scavenging capacity were endowed to inhibit Aβ fibrillization, disaggregate Aβ fibrils, and scavenge Aβ fibril-induced reactive oxygen species. An obvious inhibitory effect on Aβ fibrillization and a disaggregation effect on Aβ fibrils were observed after treatment with CuZn-PEP NZs. Meanwhile, the cytotoxicity of Aβ fibrils toward PC12 cells was significantly reduced by CuZn-PEP NZs. Meanwhile, CuZn-PEP NZs with multiple redox pairs exhibit superoxide dismutase, catalase, and glutathione peroxidase-mimicking enzyme properties simultaneously, which further display cytoprotective effects against Aβ fibril-induced reactive oxygen species and mitochondrial damage. Besides, cellular studies verified that CuZn-PEP NZs possess excellent biocompatibility and blood–brain barrier penetration capacity. Overall, these bimetallic-peptide framework nanozymes represent a promising perspective for attenuation of amyloid-β aggregation and reactive oxygen species simultaneously, which highlights the potential of nanozymes for the treatment of amyloidosis and reactive oxygen species-mediated AD progression.


  • Open Access

    Recent Advances and Future Prospects in Biological-Membrane-Targeted Polymers

    by Ran Chen, Yaping Liu, Yanan Jiang, Min Sun, Zhen Fan, Jianzhong Du

    Membrane structures play a crucial role in biological systems, not only serving as a barrier between cells/organelles and the external microenvironment but also playing key roles in important biological processes such as material exchange, signal transduction, and cell proliferation. With the advancement of related research, membrane-targeting strategies have gradually been a focus in modern cancer therapy and antimicrobial studies. Polymer materials show great promise in membrane-targeted therapy due to their excellent biocompatibility, tunability, and functionalization potential. Presented in this review are design strategies for polymer materials targeting cell and organelle membranes. Initially, we introduce the functions and characteristics of tumor cell membranes, organelle membranes, and bacterial cell walls, whose unique physicochemical properties offer potential pathways for targeted therapy. Next, we focus on various strategies for designing polymer materials with membrane targeting features. For instance, by adjusting the charge density and hydrophilicity/hydrophobicity of polymer chains, cationic polymers (e.g., polyethylenimine and polyamidoamine dendrimers) can leverage electrostatic interactions to disrupt the integrity of the cell membrane, leading to pore formation or structural disruption, which facilitates efficient cytosolic delivery. Thirdly, functionalized polymers can specifically recognize target membranes, thereby reducing side effects. Studies have demonstrated that modified polymers not only facilitate targeted delivery to specific organs but also enhance cellular uptake efficiency by up to 10 times. Finally, we discuss existing challenges and future directions of polymer materials for membrane-targeted therapeutics, aiming to provide insight for advancing membrane-targeted polymers and improving existing treatment strategies for more precise disease management.


  • A Polypeptosome Spray To Heal Antibiotic-Resistant Bacteria-Infected Wound by Photocatalysis-Induced Metabolism-Interference

    by Tao Wang, Runxin Teng, Mengjie Wu, Zhenghong Ge, Yaping Liu, Biao Yang, Chang Li, Zhen Fan, Jianzhong Du

    With the booming antimicrobial drug resistance worldwide, traditional antibacterial agents (e.g., antibiotics) are usually powerless against superbug. Targeting antibacterial pathways different from traditional antibiotics could be an effective approach to treating wounds with a resistant bacterial infection. In this work, an antibacterial polymersome was developed to physically induce bacterial membrane damage and interfere with bacterial metabolism. First, we synthesized an antibacterial poly(ε-caprolactone)-block-poly(glutamic acid)-block-poly(Lys-stat-Phe) copolymer, which was then self-assembled into polypeptosome with the amplification of surface positive charges to disrupt bacterial membranes. In addition, the polypeptosome was further decorated with photocatalytic bismuth sulfide (Bi2S3) nanoparticles as a photocatalyst to interfere with reduced nicotinamide adenine dinucleotide (NADH) conversion. Specifically, near-infrared light generated free electrons from Bi2S3 nanoparticles could effectively interfere with NADH homeostasis to induce antibiotic-resistant bacteria death, as verified by transcriptome sequence analysis. Moreover, effective healing of antibiotic-resistant bacteria-infected wounds of mice was achieved with a spray of polypeptosome dispersion. Overall, we provided a fresh strategy to integrate bacterial membrane damage and metabolism interference functions within antibacterial polymersomes for healing antibiotic-resistant bacteria-infected wound.


  • A peptide-based conductive hydrogel capable of in situ bioelectrocatalytic NADH regeneration for sustained production of 1-propanol

    by Yaping Liu, Mingchen Lv, Ran Chen, Zhuo Zhang, Runxin Teng, Jinlong Qin, Min Sun, Zhen Fan, Jianzhong Du

    Nicotinamide-adenine dinucleotide (NAD+/NADH) is a coenzyme that acts as a donor and acceptor of electrons in redox reactions within all eukaryotic cells. The reduction of NAD+ produces NADH that subsequently acts as the key electron carrier. However, limited stability of enzymes under operational conditions, unwanted by-products and limited external electron donors result in low efficiency of NADH regeneration to drive the downstream enzymatic reactions. Herein, we modularly designed a peptide hydrogel, which provided an appropriate physiological microenvironment for maintaining the bioactivity of alcohol dehydrogenase. Meanwhile, Bi nanoparticles were in situ synthesized and doped into nanofibers during the peptide self-assembly to afford a conductive hydrogel with enhanced bioelectrocatalytic efficiency. Both linear sweep voltammetry and chronoamperometry data unveiled excellent electrochemical performance of this hydrogel for sustained NADH regeneration at low potential (−0.37 V vs. RHE). Even at a relatively high potential of −0.79 V vs. RHE, the yield of NADH for 10 h was as high as 81%. The regenerated NADH could further drive propionaldehyde alcoholization to produce 1-propanol sustainably with a rate of 1.34 mM h−1 at −0.62 V (vs. RHE). Overall, this peptide-based conductive hydrogel could achieve sustained 1-propanol production by leveraging in situ bioelectrocatalytic NADH regeneration, demonstrating a promising approach for electroenzymatic biofuel and pharmaceutical production.